MedTrace Logo

Air Filtration for COPD in VA Population of Veterans

NCT05913765 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-10-23

No results posted yet for this study

Summary

The goal of this study is to investigate the effectiveness of stand-alone air filtration for improving indoor air quality (IAQ) and chronic obstructive pulmonary disease (COPD) outcomes in a high-risk urban cohort of 80 U.S. military veterans with COPD. Secondary goals of the study are to (1) investigate housing-related factors that may contribute to COPD exacerbation, (2) investigate the utility of using low-cost sensors for indoor air pollution epidemiology studies and for providing actionable or useful information on the quality of their indoor air to patients and their physicians, and (3) evaluate the costs and benefits of using stand-alone air filtration to improve IAQ and COPD outcomes.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE

Air cleaner

Austin Air Healthmate air cleaner with or without standard filter

Sponsors & Collaborators

  • Jesse Brown VA Medical Center

    collaborator FED

  • US Department of Housing and Urban Development

    collaborator FED

  • Elevate

    collaborator UNKNOWN

  • Illinois Institute of Technology

    lead OTHER

Principal Investigators

  • Israel Rubinstein, MD · Jesse Brown VA Medical Center

  • Mohammad Heidarinejad, PhD · Illinois Institute of Technology

  • Zane Elfessi, PharmD · Jesse Brown VA Medical Center

  • Kaveeta Jagota · Jesse Brown VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-11
Primary Completion
2025-10-01
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05913765 on ClinicalTrials.gov